8 weeks: ~23 vials 12 weeks: ~34 vials 16 weeks: ~45 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 16 weeks (once daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per 80 mg vial for reconstitution
All references to observed effects are strictly for educational and research purposes within appropriately controlled settings

Hepatology .2026;[Epub] CrossRef Updates on paediatric MASLD: insights from an endocrine lens Natalie Segev, Marialena Mouzaki Diabetologia .2026;[Epub] CrossRef An Integrated NanozymeExosome Platform for MultiTargeted Therapy of MetabolicAssociated Steatotic Liver Disease Kun Yu, Xinwei Li, Yingying Liu, Haonan Zhang, Guojie Liu, Tuo Ji, Yuzhi Gao, Lin Wang, Yuwei Bian, Guohua Chen, Zhiwen Zhao, Feng Wang, Xiaoming Yu, Jiachen He, Xuzhu Gao Advanced Healthcare Materials .2026;[Epub] CrossRef Safety and efficacy of pharmacological interventions for hepatic outcomes of metabolic dysfunction-associated steatotic liver disease: protocol for systematic review and network meta-analysis Kiavash Semnani, Farbod Semnani, Seyed Sahab Aarabi, Shirin Esmaeili, Ehsaneh Taheri, Armita Mahdavi-Gorabi, Mohsen Rajabnia, Shirin Djalalinia, Saba Goodarzi, Amir Kasaeian, Mohammad Shadab Siddiqui, Mostafa Qorbani BMJ Open .2026

Ozempic is a brand-name drug manufactured by Novo Nordisk that contains semaglutide